You are here

  • Home
  • Archive
  • Volume 65, Issue Suppl 1
  • OC-003 Efficacy and Safety of Golimumab Induction for Moderate to Severe Ulcerative Colitis in the United Kingdom: Results from the Go-Colitis Study

Article info

Article menu
Download PDFPDF
BSG 2016
OC-003 Efficacy and Safety of Golimumab Induction for Moderate to Severe Ulcerative Colitis in the United Kingdom: Results from the Go-Colitis Study

Authors

Citation

Probert C, Gaya D, Hamlin P, et al
OC-003 Efficacy and Safety of Golimumab Induction for Moderate to Severe Ulcerative Colitis in the United Kingdom: Results from the Go-Colitis Study
Gut 2016;65:A2-A3.

Publication history

  • First published August 17, 2016.
Online issue publication 
February 21, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions